GeneDx Holdings Corp. (WGS) is in Healthcare, Diagnostics & Research, based in United States, listed on NasdaqGS. Market cap 2.02B USD. 52-week range 32.21 to 170.87 USD. Trailing P/E 674.5. Data as of 2026-10-09.
GeneDx Holdings Corp., a genomics company, provides genetic testing services. The company primarily offers pediatric and rare disease diagnostics with a focus on whole exome and genome sequencing, as well as data and information services. It also develops an AI-based platform for next generation sequencing analysis, interpretation, and clinical reporting for rare disease, hereditary risk, and cancer testing. GeneDx Holdings Corp. was founded in 2000 and is headquartered in Stamford, Connecticut.